Event Details

BridgeBio Pharma to Discuss Topline Results from Phase 3 ATTRibute-CM Study

December 27, 2021 8:00 AM ET
This site is intended for U.S. residents.
BridgeBio, Attruby, the Attruby logo, ForgingBridges, and the ForgingBridges logo are trademarks of BridgeBio Pharma, Inc. All other trademarks are property of their respective owners.
© 2026 BridgeBio Pharma Inc. - All rights reserved
Powered By Q4 Inc. 5.187.1.9 (opens in new window)